GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » Piotroski F-Score

NeueHealth (NeueHealth) Piotroski F-Score : 3 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NeueHealth Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NeueHealth has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for NeueHealth's Piotroski F-Score or its related term are showing as below:

NEUE' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 5
Current: 3

During the past 6 years, the highest Piotroski F-Score of NeueHealth was 5. The lowest was 3. And the median was 5.


NeueHealth Piotroski F-Score Historical Data

The historical data trend for NeueHealth's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth Piotroski F-Score Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 5.00 5.00 3.00

NeueHealth Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 6.00 4.00 3.00 -

Competitive Comparison of NeueHealth's Piotroski F-Score

For the Healthcare Plans subindustry, NeueHealth's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeueHealth's Piotroski F-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where NeueHealth's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -112.832 + -633.895 + -229.716 + -15.914 = $-992 Mil.
Cash Flow from Operations was -109.002 + -1671.293 + -331.227 + -48.717 = $-2,160 Mil.
Revenue was 297.982 + 269.399 + 292.871 + 245.095 = $1,105 Mil.
Gross Profit was 52.822 + 42.961 + 28.007 + 48.221 = $172 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(4848.005 + 4393.153 + 2055.766 + 1225.48 + 1105.128) / 5 = $2725.5064 Mil.
Total Assets at the begining of this year (Mar23) was $4,848 Mil.
Long-Term Debt & Capital Lease Obligation was $66 Mil.
Total Current Assets was $974 Mil.
Total Current Liabilities was $1,260 Mil.
Net Income was -274.666 + -316.84 + -668.804 + -175.011 = $-1,435 Mil.

Revenue was 149.34 + 193.363 + 227.696 + 300.55 = $871 Mil.
Gross Profit was 18.547 + 41.213 + 27.123 + 40.43 = $127 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(5275.026 + 5261.057 + 4612.127 + 4665.052 + 4848.005) / 5 = $4932.2534 Mil.
Total Assets at the begining of last year (Mar22) was $5,275 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.
Total Current Assets was $3,771 Mil.
Total Current Liabilities was $4,012 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NeueHealth's current Net Income (TTM) was -992. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NeueHealth's current Cash Flow from Operations (TTM) was -2,160. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-992.357/4848.005
=-0.20469389

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-1435.321/5275.026
=-0.27209743

NeueHealth's return on assets of this year was -0.20469389. NeueHealth's return on assets of last year was -0.27209743. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

NeueHealth's current Net Income (TTM) was -992. NeueHealth's current Cash Flow from Operations (TTM) was -2,160. ==> -2,160 <= -992 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=66.4/2725.5064
=0.02436245

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=0/4932.2534
=0

NeueHealth's gearing of this year was 0.02436245. NeueHealth's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=974.465/1259.55
=0.77366123

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=3771.414/4011.881
=0.94006128

NeueHealth's current ratio of this year was 0.77366123. NeueHealth's current ratio of last year was 0.94006128. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

NeueHealth's number of shares in issue this year was 8.079. NeueHealth's number of shares in issue last year was 7.894. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=172.011/1105.347
=0.1556172

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=127.313/870.949
=0.14617733

NeueHealth's gross margin of this year was 0.1556172. NeueHealth's gross margin of last year was 0.14617733. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=1105.347/4848.005
=0.22800038

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=870.949/5275.026
=0.165108

NeueHealth's asset turnover of this year was 0.22800038. NeueHealth's asset turnover of last year was 0.165108. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NeueHealth has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

NeueHealth  (NYSE:NEUE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


NeueHealth Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of NeueHealth's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


NeueHealth (NeueHealth) Business Description

Traded in Other Exchanges
N/A
Address
8000 Norman Center Drive, Suite 900, Minneapolis, MN, USA, 55437
Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.
Executives
Mikan George Lawrence Iii director, officer: CEO and President 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jay Matushak officer: Chief Financial Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey S Cook officer: CEO, NeueHealth C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey J Scherman officer: Chief Accounting Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith officer: CFO & CAO TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Jeff Michael Craig officer: GC & CORPORATE SECRETARY C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Manuel Kadre director 2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt director GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p. 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson officer: CEO, Bright HealthCare C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437

NeueHealth (NeueHealth) Headlines

From GuruFocus

Bright Health Group Appoints Jay Matushak as Chief Financial Officer

By Business Wire Business Wire 05-03-2023